SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:9d423917-c3cd-42eb-9855-e06e0194c5ba"
 

Search: onr:"swepub:oai:lup.lub.lu.se:9d423917-c3cd-42eb-9855-e06e0194c5ba" > Complementary pre-s...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Boada, MercèInternational University of Catalonia,Carlos III Health Institute (author)

Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease : Results from the MOPEAD project

  • Article/chapterEnglish2022

Publisher, publication year, extent ...

  • 2021-07-26
  • Wiley,2022

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:9d423917-c3cd-42eb-9855-e06e0194c5ba
  • https://lup.lub.lu.se/record/9d423917-c3cd-42eb-9855-e06e0194c5baURI
  • https://doi.org/10.1002/alz.12441DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:147280460URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • Introduction: The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceived to explore innovative complementary strategies to uncover hidden prodromal and mild Alzheimer's disease (AD) dementia cases and to raise awareness both in the general public and among health professionals about the importance of early diagnosis. Methods: Four different strategies or RUNs were used: (a) a web-based (WB) prescreening tool, (2) an open house initiative (OHI), (3) a primary care–based protocol for early detection of cognitive decline (PC), and (4) a tertiary care–based pre-screening at diabetologist clinics (DC). Results: A total of 1129 patients at high risk of having prodromal AD or dementia were identified of 2847 pre-screened individuals (39.7%). The corresponding proportion for the different initiatives were 36.8% (WB), 35.6% (OHI), 44.4% (PC), and 58.3% (DC). Conclusion: These four complementary pre-screening strategies were useful for identifying individuals at high risk of having prodromal or mild AD.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Rodrigo, AdriánGMV SECURE E SOLUTIONS (author)
  • Jessen, FrankUniversity Hospital of Cologne (author)
  • Wimblad, BengtKarolinska Institute,Karolinska University Hospital (author)
  • Kramberger, MilikaUniversity Medical Centre Ljubljana (author)
  • Visser, Pieter JelleVrije Universiteit Amsterdam,Maastricht University (author)
  • Simó, RafaelAutonomous University of Barcelona,CIBER Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) (author)
  • Rodríguez-Gomez, OctavioInternational University of Catalonia (author)
  • Ciudin, AndreeaCIBER Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM),Autonomous University of Barcelona (author)
  • Georges, JeanAlzheimer Europe (author)
  • Dumas, AnneteASDM Consulting (author)
  • Maguire, PeggyEuropean Institute of Women's Health (author)
  • Krivec, DavidSpomincica Alzeimer Slovenia (author)
  • Wimo, AndersKarolinska Institutet,Karolinska Institute (author)
  • Valero, SergiCarlos III Health Institute,International University of Catalonia (author)
  • Alegret, MontserratCarlos III Health Institute,International University of Catalonia (author)
  • Jamilis, LauraGMV SECURE E SOLUTIONS (author)
  • Zwan, MarissaVrije Universiteit Amsterdam (author)
  • Sannemann, LenaUniversity Hospital of Cologne (author)
  • Arrufat, JordiEAP Sarrià-Vallvidrera-Les Planes (author)
  • Stomrud, ErikLund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups,Emmaboda Health Centre(Swepub:lu)med-esr (author)
  • Johansson, GunillaKarolinska Institutet,Karolinska Institute (author)
  • Shering, CraigAstraZeneca, UK (author)
  • Glaysher, BridgetModus Research and Innovation Limited (author)
  • Stewart, NeilModus Research and Innovation Limited (author)
  • Belger, MarkEli Lilly and Company (author)
  • Iradier, FatimaLilly España (author)
  • Campo, LauraEli Lilly and Company (author)
  • International University of CataloniaCarlos III Health Institute (creator_code:org_t)
  • MOPEAD consortium

Related titles

  • In:Alzheimer's and Dementia: Wiley18:6, s. 1119-11271552-52601552-5279

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view